StockData
Cryo-Cell International Inc logo

Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30
$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

Cryo-Cell International profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Cryo-Cell International's profit margin for the twelve months ending Aug 31, 2026 was -6.2%. For fiscal 2025 it was -7.7%, against 1.3% the year before. The highest annual figure on record is 38.4% in fiscal 2015.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Nov 30, 2025-7.7%−9.0
FY2024Nov 30, 20241.3%+31.6
FY2023Nov 30, 2023-30.4%−39.5
FY2022Nov 30, 20229.1%+1.9
FY2021Nov 30, 20217.2%−4.4
FY2020Nov 30, 202011.6%+4.4
FY2019Nov 30, 20197.2%+10.1
FY2018Nov 30, 2018-2.9%−12.0
FY2017Nov 30, 20179.1%+14.8
FY2016Nov 30, 2016-5.7%−44.1
FY2015Nov 30, 201538.4%+35.7
FY2014Nov 30, 20142.8%+2.6
FY2013Nov 30, 20130.1%+35.3
FY2012Nov 30, 2012-35.1%−23.4
FY2011Nov 30, 2011-11.7%−31.2
FY2010Nov 30, 201019.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ3 2026Aug 31, 202616.2%+6.7
Q2 FY2026CQ2 2026May 31, 20267.1%+2.6
Q1 FY2026CQ1 2026Feb 28, 20260.6%−2.9
Q4 FY2025CQ4 2025Nov 30, 2025-48.7%−25.5
Q3 FY2025CQ3 2025Aug 31, 20259.6%−3.5
Q2 FY2025CQ2 2025May 31, 20254.5%−3.7
Q1 FY2025CQ1 2025Feb 28, 20253.5%−3.5
Q4 FY2024CQ4 2024Nov 30, 2024-23.2%+118.9
Q3 FY2024CQ3 2024Aug 31, 202413.0%+4.4
Q2 FY2024CQ2 2024May 31, 20248.2%+5.3
Q1 FY2024CQ1 2024Feb 29, 20247.1%−2.7
Q4 FY2023CQ4 2023Nov 30, 2023-142.1%−152.9
Q3 FY2023CQ3 2023Aug 31, 20238.6%+2.6
Q2 FY2023CQ2 2023May 31, 20232.8%−5.5
Q1 FY2023CQ1 2023Feb 28, 20239.8%−1.7
Q4 FY2022CQ4 2022Nov 30, 202210.8%+19.5
Q3 FY2022CQ3 2022Aug 31, 20226.1%−5.3
Q2 FY2022CQ2 2022May 31, 20228.3%−7.9
Q1 FY2022CQ1 2022Feb 28, 202211.5%+1.4
Q4 FY2021CQ4 2021Nov 30, 2021-8.7%−24.6
Q3 FY2021CQ3 2021Aug 31, 202111.4%+1.7
Q2 FY2021CQ2 2021May 31, 202116.2%+4.1
Q1 FY2021CQ1 2021Feb 28, 202110.1%+1.1
Q4 FY2020CQ4 2020Nov 30, 202015.9%+5.3
Q3 FY2020CQ3 2020Aug 31, 20209.7%−3.9
Q2 FY2020CQ2 2020May 31, 202012.1%+11.5
Q1 FY2020CQ1 2020Feb 29, 20209.0%+5.3
Q4 FY2019CQ4 2019Nov 30, 201910.6%+0.2
Q3 FY2019CQ3 2019Aug 31, 201913.6%+10.5
Q2 FY2019CQ2 2019May 31, 20190.7%−7.6
Q1 FY2019CQ1 2019Feb 28, 20193.7%+44.3
Q4 FY2018CQ4 2018Nov 30, 201810.4%−0.1
Q3 FY2018CQ3 2018Aug 31, 20183.1%−6.3
Q2 FY2018CQ2 2018May 31, 20188.3%+0.3
Q1 FY2018CQ1 2018Feb 28, 2018-40.6%−49.1
Q4 FY2017CQ4 2017Nov 30, 201710.5%−3.3
Q3 FY2017CQ3 2017Aug 31, 20179.5%–
Q2 FY2017CQ2 2017May 31, 20178.0%–
Q1 FY2017CQ1 2017Feb 28, 20178.4%–
Q4 FY2016CQ4 2016Nov 30, 201613.8%–

More Cryo-Cell International figures

See a number that looks wrong?